Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in british columbia during its expansion period from 1998-2006

Substance Use and Misuse

Volumn 48, Issue 8, 2013, Pages 671-682

  Sharif, Behnam ^a   Nosyk, Bohdan ^b   Sun, Huiying ^c   Marsh, David C ^d   Anis, Aslam ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c Canadian HIV Trials Network   (Canada)

^d NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Charlson comorbidity index; Chronic disease score; Coexisting chronic diseases; Methadone maintenance treatment; Opioid dependence; Substance abuse treatment

Indexed keywords

METHADONE;

ADULT; AGE; ARTICLE; CANADA; CHRONIC DISEASE; COMORBIDITY; FEMALE; HUMAN; MALE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT ATTITUDE; REGRESSION ANALYSIS; SEX DIFFERENCE; SOCIAL CLASS; STATISTICS;

ADULT; AGE FACTORS; BRITISH COLUMBIA; CANADA; CHRONIC DISEASE; COMORBIDITY; FEMALE; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; REGRESSION ANALYSIS; SEX FACTORS; SOCIAL CLASS;

EID: 84879128995     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2013.800119     Document Type: Article

References (43)

1. Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28, 321-329.
2. Anderson, J. F., & Warren, L. D. (1999). Client retention in the British Columbia Methadone Program, 1996-1999. Canadian Journal of Public Health, 95, 104-109.
3. BC Census and Vital Statistics Agency. (2001). Census. Retrieved January 2011, from http://www.vs.gov.bc.ca/stats.
4. Bell, J., & Butler, B. (2010). Health care utilization and morbidity associated with methadone and buprenorphine treatment. Heroin Addiction And Related Clinical Problems, 10, 21-26.
5. Brands, B. R., Blake, J.,&Marsh, D. (2002). Changing patient characteristics with increased methadone maintenance availability. Drug and Alcohol Dependence, 66, 11-20.
6. Brands, B. R., Marsh, D., Hart, L., & Jamieson, B. (2002a). Literature review methadone maintenance treatment. For the office of Canada's Drug Strategy, Health Canada. Retrieved March 2012, from http://www.hc-sc.gc.ca/ hc-ps/pubs/adp-apd/methadone/index-eng.php.
7. Brands, B. R., Marsh, D., & Hart, L. (2002b). Best practices. Methadone maintenance treatment/meilleures pratiques: Traitement d'entretien ̀a la ḿethadone. Ottawa, ON: Health Canada. Retrieved March 2012, fromhttp://www.hc-sc.gc.ca/hlvs/pubs/adp-apd/index e.html.
8. Buxton, J. (2005). Vancouver drug use epidemiology 2007. Vancouver site report for the Canadian community epidemiology network on drug use (CCENDU), Retrieved September 2011, from http://www.ccsa.ca.
9. Darke, S., Kaye, S., & Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction (Abingdon, England), 101, 1299-1305.
10. Darke, S., Ross, J., & Teesson, M. (2007). The Australian Treatment Outcome Study (ATOS):What have we learnt about treatment for heroin dependence Drug and Alcohol Review, 26, 49-54.
11. Degenhardt, L., Randall, D., Hall,W., Law,M., Butler, T., & Burns, L. (2009). Mortality among clients of a statewide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug and Alcohol Dependence, 105, 9-15.
12. Deyo, R., Cherkin, D., & Ciol, M. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative database. Journal of Clinical Epidemiology, 45, 613-619.
13. Dhalla, I.A,Mamdani,M.M., Sivilotti, M. L. A,Kopp, A.,Qureshi, O., & Juurlink, D. N. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of longacting oxycodone. CMAJ: Canadian Medical Association Journal, 181, 891-896.
14. Fareed, A., Musselman, D., Byrd-Sellers, J., Vayalapalli, S., Casarella, J., Drexler, K., et al. (2010). On-site basic health screening and brief health counseling of chronic medical conditions for veterans in methadone maintenance treatment. Journal of Addiction Medicine, 4, 160-166.
15. Fischer, B. (2000). Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. Journal of Public Health Policy, 21, 187-210.
16. Galea, S., & Vlahov, D. (2002). Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Reports, 117(Suppl. 1), S135-S145.
17. Gerra, D., Maremmani, M., & Capovani, M. (2009). Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution" Subst Use Misuse, 44(5), 663-671.
18. Ghate, S. R., Haroutiunian, S., Winslow, R., & McAdam-Marx, C. (2010). Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: A comparison of two recently published studies. Journal of Pain and Palliative Care Pharmacotherapy, 24, 251-258.
19. Hart, A. N. (2007). Report of the Methadone Maintenance Tretament Practices Task Force., Deputy Minster of health and Longterm Care. Ontario, Canada: Longwood Publishing company.
20. Howard, A. A., Klein, R. S., & Schoenbaum, E. E. (2010). Associaton of Hepatitis C infection and Antretroviral Use with Diabetes Mellitus in Drug Users. Clinical Infectious Diseases, 36, 1318-1323.
21. Kendall, P. R. W. (2011). Report from the Office of the Provincial Health Officer. Decreasing HIV Infections Among People Who Use Drugs By Injection In British Columbia: Potential explanations and recommendations for further action. British Columbia: Provincial Health Officer. Retrieved May, 2011 from http://www.health.gov.bc.ca/library/publications/year/2011/decreasing-HIV-in- IDU-population.pdf
22. Kim, T. W., Alford, D. P., Holick, M. F., Malabanan, A. O., & Samet, J. H. (2009). Low Vitamin D status of patients in methadone maintenance treatment. Journal of Addiction Medicine, 3, 134-138.
23. Luce, J., & Strike, C. (2011). A cross Canada scan of methadone maintenance treatment policy developments. A report prepared for the Canadian Executive Council on Addictions. Retrieved March 2012 from http://www.ccsa.ca/ ceca/pdf/CECA MMT Policy Scan April 2011.pdf
24. Manning, W. G., & Mullahy, J. (2001). Estimating log models: To transform or not to transform Journal of Health Economics, 20, 461-494.
25. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 4, 1-31.
26. Merrill, J. O., Jackson, T. R., Schulman, B. A, Saxon, A. J., Awan, A., Kapitan, S., et al. (2005).Methadone medical maintenance in primary care. An implementation evaluation. Journal of General Internal Medicine, 20, 344-349.
27. Methadone maintenance handbook. (2009). The College of Physicians and Surgeons of British Columbia. Retrieved September 2011 from http://www.cpsbc.ca
28. Needham, D., Scales, D., Laupacis, A, & Pronovost, P. (2005). A systematic review of the Charlson comorbidity index using Canadian administrative databases: A perspective on risk adjustment in critical care research. Journal of Critical Care, 20, 12-19.
29. Nosyk, B., MacNab, Y. C., Sun, H., Fischer, B., Marsh, D. C., Schechter, M. T., et al. (2009). Proportional hazards frailty models for recurrent methadone maintenance treatment. American Journal of Epidemiology, 170, 783-792.
30. Nosyk, B., Marsh, D. C., Sun, H., Schechter, M. T., & Anis, A. H. (2010). Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. Journal of Substance Abuse Treatment, 39, 22-31.
31. PharmaNet: (1996). Ministry of Health Services. Retrieved January 2011 from: http://www.health.gov.bc.ca/pharmacare/pharmanet/netindex.html
32. Popova, S., Rehm, J., & Fischer, B. (2006.) An overview of illegal opioid use and health services utilization in Canada. Public Health, 120, 320-328.
33. Population Data BC (2009). Multi-university platform-BC's panprovincial population health data services. Retrieved January 2011 from http://www.popdata.bc.ca
34. Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., et al. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43, 1130-1139.
35. Reist, D. (2010). Methadone maintenance treatment in British Columbia, 1996-2008. Analysis and Recommendations. Victoria, BC, Canada: University of Victoria, Center for addictions research BC; report for Ministry of Healthy Living and Sport.
36. Schneeweiss, S., & Maclure, M. (2000). Use of comorbidity scores for control of confounding in studies using administrative databases. International Journal of Epidemiology, 29, 891-898.
37. Shah, N. G., Celentano, D. D., Vlahov, D., Stambolis, V., Johnson, L., Nelson, K. E., et al. (2000). Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS (London, England), 14, 2035-2043.
38. Strike, C. J., Urbanoski,K., Fischer, B., Marsh, D. C.,&Millson, M. (2005). Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001. Journal of Addictive Diseases, 24, 39-51.
39. Sylla, L., Bruce, R., & Kamarulzaman, A. (2007). Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Journal of Drug Policy, 18, 306-312.
40. Von Korff, M., Wagner, E. H., & Saunders, K. (1992). A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology, 45, 197-203.
41. World Health Organization (WHO). (2004). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. United Nations office on Drugs and crime-WHO/UNAIDS position paper. Retrieved March 2012 from http://www.who.int/substance abuse/publications/en/PositionPaper English.pdf
42. Wittchen, H.-U., Apelt, S. M., Soyka, M., Gastpar, M., Backmund, M., G̈olz, J., et al. (2008). Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug and Alcohol Dependence, 95, 245-257.
43. Zhang, X., Decker, F. H., Luo, H., Geiss, L. S., Pearson, W. S., Saaddine, J. B., et al. (2010). Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. Journal of the American Geriatrics Society, 58, 724-730.